QCG
FOLD

Quadrant Capital Group’s Amicus Therapeutics FOLD Stock Holding History

Quadrant Capital Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.5K Hold
1,350
– – ﹤0.01% 2004
2025
Q4 		$19.2K Hold
1,350
– – ﹤0.01% 2010
2025
Q3 		$10.6K Buy
+1,350
New +$9.61K ﹤0.01% 2145
2024
Q4 		– Sell
-14
Closed -$150 – 2758
2024
Q3 		$150 Hold
14
– – ﹤0.01% 2719
2024
Q2 		$139 Hold
14
– – ﹤0.01% 2683
2024
Q1 		$165 Sell
14
-125
-90% -$1.6K ﹤0.01% 2700
2023
Q4 		$1.97K Buy
+139
New +$1.58K ﹤0.01% 2476
2023
Q3 		– Sell
-725
Closed -$9.11K – 2715
2023
Q2 		$9.11K Hold
725
– – ﹤0.01% 2032
2023
Q1 		$8.04K Buy
+725
New +$8.94K ﹤0.01% 2112
2022
Q3 		– Sell
-28
Closed – – 2694
2022
Q2 		$0 Sell
28
-640
-96% -$5.27K ﹤0.01% 2596
2022
Q1 		$6K Hold
668
– – ﹤0.01% 1844
2021
Q4 		$8K Sell
668
-83
-11% -$925 ﹤0.01% 1713
2021
Q3 		$7K Buy
751
+67
+10% +$685 ﹤0.01% 1747
2021
Q2 		$7K Hold
684
– – ﹤0.01% 1721
2021
Q1 		$7K Sell
684
-20
-3% -$310 ﹤0.01% 1643
2020
Q4 		$16K Hold
704
– – ﹤0.01% 1187
2020
Q3 		$10K Buy
704
+20
+3% +$292 ﹤0.01% 1222
2020
Q2 		$10K Hold
684
– – ﹤0.01% 1324
2020
Q1 		$6K Sell
684
-167
-20% -$1.59K ﹤0.01% 1580
2019
Q4 		$8K Buy
+851
New +$7.79K ﹤0.01% 1956

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Quadrant Capital Group's FOLD Position: Q1 2026 in Review

Quadrant Capital Group held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 1,350 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Quadrant Capital Group first reported a position in FOLD in Q4 2019 and has held it in 20 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Quadrant Capital Group held 1,350 shares of Amicus Therapeutics worth $19.5K as of Q1 2026.
  • Quadrant Capital Group left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2004 holding.
  • Quadrant Capital Group first reported a position in Amicus Therapeutics in Q4 2019 and has held it in 20 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.